Log In
BCIQ
Print this Print this
 

SoluMatrix meloxicam, meloxicam (Vivlodex)

Also known as: IP 045

  Manage Alerts
Collapse Summary General Information
Company Iroko Pharmaceuticals LLC
DescriptionLow-dose formulation of the NSAID meloxicam using SoluMatrix Fine Particle technology
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA) pain in adults
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today